RNC Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-1,119
| Closed | -$216K | – | 150 |
|
2018
Q3 | $216K | Sell |
1,119
-105
| -9% | -$20.3K | 0.01% | 131 |
|
2018
Q2 | $208K | Sell |
1,224
-500
| -29% | -$85K | 0.01% | 132 |
|
2018
Q1 | $281K | Sell |
1,724
-210
| -11% | -$34.2K | 0.02% | 119 |
|
2017
Q4 | $290K | Buy |
1,934
+191
| +11% | +$28.6K | 0.02% | 119 |
|
2017
Q3 | $265K | Sell |
1,743
-1,235
| -41% | -$188K | 0.02% | 122 |
|
2017
Q2 | $384K | Buy |
2,978
+150
| +5% | +$19.3K | 0.03% | 102 |
|
2017
Q1 | $309K | Buy |
+2,828
| New | +$309K | 0.02% | 110 |
|
2015
Q3 | – | Sell |
-1,919
| Closed | -$237K | – | 134 |
|
2015
Q2 | $237K | Sell |
1,919
-545
| -22% | -$67.3K | 0.02% | 118 |
|
2015
Q1 | $291K | Sell |
2,464
-392
| -14% | -$46.3K | 0.02% | 105 |
|
2014
Q4 | $339K | Buy |
2,856
+738
| +35% | +$87.6K | 0.03% | 105 |
|
2014
Q3 | $238K | Buy |
+2,118
| New | +$238K | 0.02% | 108 |
|